Total Payments
$710.86
2024 Payments
$307.04
Companies
13
Transactions
24
Medicare Patients
12,255
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$698.12 (98.2%)
Education$12.74 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $698.12 | 23 | 98.2% |
| Education | $12.74 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $117.36 | 1 | $0 (2024) |
| Allergan, Inc. | $116.93 | 5 | $0 (2022) |
| ABBVIE INC. | $78.14 | 3 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $72.80 | 2 | $0 (2024) |
| Oasis Medical, Inc. | $69.00 | 1 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $44.85 | 2 | $0 (2023) |
| Thea Pharma Inc. | $42.22 | 2 | $0 (2023) |
| Aerie Pharmaceuticals, Inc. | $39.57 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $38.94 | 2 | $0 (2021) |
| Amgen Inc. | $34.16 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $307.04 | 7 | Optinose US, Inc. ($117.36) |
| 2023 | $67.17 | 3 | Bausch & Lomb Americas Inc. ($44.85) |
| 2022 | $58.21 | 3 | Allergan, Inc. ($22.75) |
| 2021 | $159.54 | 5 | Oasis Medical, Inc. ($69.00) |
| 2020 | $61.12 | 3 | Allergan, Inc. ($24.46) |
| 2018 | $37.34 | 2 | Aerie Pharmaceuticals, Inc. ($24.60) |
| 2017 | $20.44 | 1 | Allergan Inc. ($20.44) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $38.18 | General |
| Category: Ophthalmology | ||||||
| 09/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: Ophthalmology | ||||||
| 08/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/19/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $117.36 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/27/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/17/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: EYE CARE | ||||||
| 01/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: EYE CARE | ||||||
| 12/17/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug), VYZULTA | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Ophthalmology | ||||||
| 11/01/2023 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/21/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), PROLENSA | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Ophthalmology | ||||||
| 09/28/2022 | Thea Pharma Inc. | — | Food and Beverage | In-kind items and services | $19.90 | General |
| 07/06/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/26/2022 | Allergan, Inc. | VUITY (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/02/2021 | Eyevance Pharmaceuticals LLC | Tobradex ST (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Anti-Infective/Steroid | ||||||
| 10/06/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: DRY EYE | ||||||
| 06/09/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/26/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: DRY EYE | ||||||
| 03/26/2021 | Oasis Medical, Inc. | OASIS TEARS (Drug) | Food and Beverage | Cash or cash equivalent | $69.00 | General |
| Category: PRESERVATIVE-FREE LUBRICANT EYE | ||||||
| 11/24/2020 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Glaucoma | ||||||
| 11/18/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/02/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Ophthalmology | ||||||
| 06/13/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Education | In-kind items and services | $12.74 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/20/2017 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $20.44 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,375 | 5,310 | $795,665 | $307,734 |
| 2022 | 15 | 3,161 | 4,937 | $712,680 | $283,347 |
| 2021 | 16 | 3,202 | 5,214 | $785,225 | $305,783 |
| 2020 | 16 | 2,517 | 4,090 | $642,950 | $245,917 |
Total Patients
12,255
Total Services
19,551
Medicare Billing
$1.1M
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 611 | 1,082 | $227,375 | $111,944 | 49.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 333 | 658 | $105,280 | $48,760 | 46.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 388 | 789 | $102,570 | $42,904 | 41.8% |
| 92250 | Photography of the retina | Office | 2023 | 468 | 678 | $98,310 | $20,343 | 20.7% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 40 | 145 | $36,000 | $14,678 | 40.8% |
| 92134 | Imaging of retina | Office | 2023 | 289 | 427 | $34,160 | $14,429 | 42.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 29 | 39 | $46,800 | $11,300 | 24.1% |
| 92132 | Imaging of front third of eye | Office | 2023 | 336 | 424 | $27,560 | $10,222 | 37.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 346 | 443 | $33,225 | $9,945 | 29.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 176 | 190 | $15,200 | $5,088 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $16,060 | $4,909 | 30.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 37 | 37 | $9,250 | $4,699 | 50.8% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 15 | 28 | $8,400 | $3,284 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $4,250 | $1,802 | 42.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 187 | 202 | $10,100 | $1,682 | 16.7% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 30 | 74 | $18,500 | $1,280 | 6.9% |
| 92285 | Photography of content of eyes | Office | 2023 | 22 | 25 | $2,625 | $465.06 | 17.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 560 | 892 | $187,320 | $92,502 | 49.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 334 | 763 | $122,080 | $57,077 | 46.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 368 | 767 | $99,710 | $41,854 | 42.0% |
| 92250 | Photography of the retina | Office | 2022 | 420 | 556 | $80,620 | $17,151 | 21.3% |
| 92134 | Imaging of retina | Office | 2022 | 271 | 397 | $31,760 | $13,309 | 41.9% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 38 | 122 | $30,000 | $12,925 | 43.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 315 | 406 | $30,450 | $9,271 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 67 | 67 | $24,455 | $9,226 | 37.7% |
About Dr. Larisa Canter, M.D
Dr. Larisa Canter, M.D is a Ophthalmology healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265506067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Larisa Canter, M.D has received a total of $710.86 in payments from pharmaceutical and medical device companies, with $307.04 received in 2024. These payments were reported across 24 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($698.12).
As a Medicare-enrolled provider, Canter has provided services to 12,255 Medicare beneficiaries, totaling 19,551 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Newport Beach, CA
- Active Since 11/20/2006
- Last Updated 06/16/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265506067
Products in Payments
- Xhance (Drug) $117.36
- LUMIGAN (Drug) $87.04
- Cequa (Drug) $72.80
- OASIS TEARS (Drug) $69.00
- RESTASIS MULTIDOSE (Drug) $49.28
- XIIDRA (Drug) $38.94
- VUITY (Drug) $38.31
- VYZULTA (Drug) $34.69
- TEPEZZA (Biological) $34.16
- Rhopressa (Drug) $24.60
- Tobradex ST (Drug) $24.01
- MIEBO (Drug) $22.90
- IYUZEH (Drug) $22.32
- XDEMVY (Drug) $20.14
- rhopressa (Drug) $14.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Newport Beach
Dr. Sheri Rowen, Md, MD
Ophthalmology — Payments: $1.0M
Ophthalmology $1.0M
Mr. David Wirta, Md, MD
Ophthalmology — Payments: $890,793
Ophthalmology $890,793
Dr. Ehsan Sadri, M.d, M.D
Ophthalmology — Payments: $413,628
Ophthalmology $413,628
Alena Reznik, M.d, M.D
Ophthalmology — Payments: $122,470
Ophthalmology $122,470
Arlene Gwon, Md, MD
Ophthalmology — Payments: $86,643
Ophthalmology $86,643
Dr. Jacob Reznik, M.d, M.D
Ophthalmology — Payments: $42,236
Ophthalmology $42,236